Max India
Max India Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Max India
Start SIPMax India Investment Rating
-
Master Rating:
-
Max India has an operating revenue of Rs. 201.03 Cr. on a trailing 12-month basis. An annual revenue de-growth of -10% needs improvement, Pre-tax margin of -1% needs improvement, ROE of -1% is poor and needs improvement. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 16% and 15% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 6% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 21 which is a POOR score indicating inconsistency in earnings, a RS Rating of 70 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 54 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of B is close to being the best. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|
Oper Rev Qtr Cr | 8 | 8 | 8 | 8 | 9 |
Operating Expenses Qtr Cr | 7 | 6 | 6 | 6 | 6 |
Operating Profit Qtr Cr | 2 | 2 | 2 | 3 | 2 |
Depreciation Qtr Cr | 1 | 1 | 1 | 1 | 1 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 0 | -2 | 0 | 1 | 1 |
Net Profit Qtr Cr | 1 | 8 | 1 | 2 | 2 |
Max India Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹95.99
- 50 Day
- ₹92.21
- 100 Day
- ₹90.51
- 200 Day
- ₹88.06
- 20 Day
- ₹95.66
- 50 Day
- ₹89.3
- 100 Day
- ₹89.65
- 200 Day
- ₹89.67
Max India Resistance and Support
Resistance | |
---|---|
First Resistance | ₹106.67 |
Second Resistance | ₹108.64 |
Third Resistance | ₹111.27 |
RSI | 71.74 |
MFI | 73.84 |
MACD Single Line | 2.1 |
MACD | 3.02 |
Support | |
---|---|
First Resistance | ₹102.07 |
Second Resistance | ₹99.44 |
Third Resistance | ₹97.47 |
Max India Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 179,695 | 10,089,874 | 56.15 |
Week | 234,111 | 15,289,789 | 65.31 |
1 Month | 137,889 | 8,744,946 | 63.42 |
6 Month | 131,169 | 7,426,796 | 56.62 |
Max India Result Highlights
Max India Synopsis
NSE-Medical-Hospitals
Max India belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 32.54 Cr. and Equity Capital is Rs. 43.03 Cr. for the Year ended 31/03/2023. Max India Ltd. is a Public Limited Listed company incorporated on 23/01/2019 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74999MH2019PLC320039 and registration number is 320039.Market Cap | 447 |
Sales | 33 |
Shares in Float | 2.11 |
No of funds | 16 |
Yield |
Book Value | 0.52 |
U/D Vol ratio | 1.2 |
LTDebt / Equity | |
Alpha | 0.11 |
Beta | 0.71 |
Max India
Owner Name | Mar-23 | Dec-22 | Sep-22 | Aug-22 |
---|---|---|---|---|
Promoters | 51.11% | 51.11% | 51.11% | 51.11% |
Mutual Funds | ||||
Foreign Portfolio Investors | 11.26% | 11.38% | 7.55% | 4.47% |
Financial Institutions/ Banks | ||||
Individual Investors | 32.99% | 32.08% | 28.34% | 22.4% |
Others | 4.64% | 5.43% | 13% | 22.02% |
Max India Management
Name | Designation |
---|---|
Mr. Analjit Singh | Founder & Chairman |
Ms. Tara Singh Vachani | Vice Chairperson |
Mr. Rajit Mehta | Managing Director |
Mr. Mohit Talwar | Non Executive Director |
Mr. Pradeep Pant | Independent Director |
Mr. Ashok Kacker | Independent Director |
Ms. Sharmila Tagore | Independent Director |
Ms. Bhawna Agarwal | Independent Director |
Mr. Niten Malhan | Independent Director |
Mr. Rohit Kapoor | Independent Director |
Dr. Ajit Singh | Independent Director |
Max India Forecast
Price Estimates
Max India Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-05-25 | Audited Results | |
2023-02-02 | Quarterly Results | |
2022-08-04 | Quarterly Results | |
2022-05-25 | Audited Results | |
2022-01-25 | Quarterly Results |
Max India FAQs
What is Share Price of Max India ?
Max India share price is ₹103 As on 04 June, 2023 | 20:13
What is the Market Cap of Max India ?
The Market Cap of Max India is ₹447.3 Cr As on 04 June, 2023 | 20:13
What is the P/E ratio of Max India ?
The P/E ratio of Max India is -37.8 As on 04 June, 2023 | 20:13
What is the PB ratio of Max India ?
The PB ratio of Max India is 0.8 As on 04 June, 2023 | 20:13